Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹13Cr
Chemicals - Alcohol - based
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TULASEEBIOE
VS
| Quarter | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | | | | | | | | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | | |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 33.3 | 50.0 | 0.0 | -100.0 | -50.0 | | 0.0 | 50.0 | -33.3 | -16.7 | -50.0 | -100.0 |
| | | | | | | | | | | | |
| 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | | | | | | | | | | |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | | |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | -1,398.1 | -211.6 | -49.2 | 1.7 | 381.4 | -132.1 | 8.3 | 9.9 | -5.2 | 3.4 | -38.9 |
| | | | | | | | | | | | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | -0.3 | -0.2 | -0.2 | -0.2 | -0.2 | -0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| -4 | -4 | -5 | -5 | -5 | -4 | -5 | -5 | -5 | -5 | -5 | -5 |
Current Liabilities Current LiabilitiesCr | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 |
Non Current Assets Non Current AssetsCr | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 5 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 100.0 | 98.8 | 0.4 | -0.1 | 19.4 | -2.8 | 0.3 | 2.9 |
CFO To EBITDA CFO To EBITDA% | 100.0 | 98.8 | -0.3 | -0.1 | 19.4 | -2.8 | 0.3 | 2.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 7 | 0 | 0 | 0 | 7 | 0 | 10 | 17 | 12 | 12 | 10 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | | | | | | | | | | | |
Price To Book Price To Book | 4.7 | 0.0 | 0.0 | 0.0 | 7.6 | 0.0 | 7.9 | 15.1 | 12.7 | 14.4 | 14.2 |
| -4,802.1 | -145.8 | -55.8 | -38.4 | -80.7 | -11.7 | -107.5 | -165.6 | -152.6 | -143.4 | -134.4 |
Profitability Ratios Profitability Ratios |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| 0.0 | -0.6 | -1.5 | -2.2 | -2.2 | 6.0 | -1.9 | -1.8 | -1.6 | -1.7 | -1.6 |
| -0.2 | -2.8 | -9.4 | -16.2 | -19.0 | 34.8 | -12.6 | -13.0 | -13.3 | -16.2 | -18.6 |
| 0.0 | -0.5 | -1.4 | -2.1 | -2.0 | 5.8 | -1.8 | -1.7 | -1.5 | -1.6 | -1.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Tulasee Bio-Ethanol Ltd is an Indian public limited company originally established for the **manufacturing of Liquid Chemicals**. While the company maintains its corporate identity, physical infrastructure, and listing status on the **BSE (Bombay Stock Exchange)**, it is currently navigating a period of operational dormancy.
### Current Operational Status and Asset Base
The company is formally classified as **presently inactive** in its core manufacturing operations. Despite this lack of active production, the management maintains the essential physical and legal framework required for a potential restart or corporate action.
* **Manufacturing Infrastructure:** The company’s primary asset base is located at **Plot No. 41/3 & 41/5, Village Lohop, Raigad, Maharashtra**. This site serves as both the registered office and the manufacturing facility.
* **Asset Integrity:** Management maintains **proper records of fixed assets**, including comprehensive quantitative details and location tracking. All **title deeds for immovable property** are held securely in the name of the company.
* **Inventory Management:** Even in its inactive state, the company conducts **physical verification of inventory** at reasonable intervals. Recent audits indicate that no material discrepancies have been reported between physical stock and book records.
* **Regulatory Scope:** Due to its inactive status, the company is currently exempt from many specific industry-related operational laws, focusing instead on **standard corporate and statutory compliance**.
### Capital Structure and Shareholder Equity
Tulasee Bio-Ethanol Ltd maintains a stable capital structure characterized by a lack of recent dilution. The company has not engaged in **buybacks, sweat equity issuances, bonus shares, or Employee Stock Option Plans (ESOPs)** in recent reporting periods.
**Equity Position (as of June 2024):**
| Particulars | Number of Shares | Amount (INR) |
| :--- | :--- | :--- |
| **Authorised Equity Share Capital** (Rs. **10** par) | **60,00,000** | **6,00,00,000** |
| **Issued Equity Share Capital** (Rs. **10** par) | **60,00,000** | **6,00,00,000** |
| **Subscribed and Paid-up Capital** | **58,93,100** | **5,89,31,000** |
| **Less: Calls in Arrears** | — | **(6,10,200)** |
| **Total Net Paid-up Capital** | **58,93,100** | **5,83,20,800** |
**Key Financial Metrics:**
* **Face Value:** Rs. **10** per equity share.
* **Net Paid-up Value:** Approximately Rs. **5.83 Crore**.
* **Arrears:** The capital reflects **Rs. 6,10,200** in calls in arrears, which is deducted from the subscribed capital to arrive at the net paid-up figure.
### Corporate Governance and Management Oversight
The company operates as a **standalone entity** with no **Subsidiaries, Joint Ventures, or Associate Companies**. Governance is managed through a structured Board and specialized committees.
* **Board Composition:** The Board consists of **four members**:
* **1 Executive Director**
* **1 Non-Executive Women Director**
* **2 Non-Executive Independent Directors**
* **Leadership:** **Mr. Kapil Nagpal** serves as the **Managing Director**. Management has recommended his re-appointment for a further **5-year term** to ensure leadership continuity.
* **Audit Committee:** This committee is composed of **two Independent Directors** and **one Non-Executive Director**, providing oversight of financial reporting and internal controls.
* **External Service Providers:**
* **Statutory Auditors:** **M/s. A. C. Jhaveri & Associates** (Appointed through **2027**).
* **Registrar & Transfer Agent (RTA):** **MUFG Intime India Private Limited** (formerly known as Link Intime India Pvt Ltd).
### Compliance Framework and Risk Profile
As a listed entity, Tulasee Bio-Ethanol Ltd adheres to the **Indian Accounting Standards (Ind AS)**, preparing its financial statements on an **accrual basis**. It is specifically categorized as a **non-investment/non-banking** entity.
* **Internal Audit Deficiency:** A notable area of non-compliance is **Section 138 of the Companies Act, 2013**. The company has **not yet appointed an Internal Auditor**, which remains a primary governance risk.
* **Vigilance and Ethics:** The company has implemented a **Whistle Blower Policy (Vigil Mechanism)**. This framework allows directors and employees to report concerns regarding unethical behavior, actual or suspected fraud, or violations of the company’s code of conduct without fear of victimization.
* **Financial Integrity:** Despite the lack of an internal auditor, the statutory auditors have noted that the company maintains adequate records and performs regular reconciliations of its physical assets and inventory.